The role of high frequency dynamic threshold (HiDT) serum carcinoembryonic antigen (CEA) measurements in colorectal cancer surveillance: A (revisited) hypothesis paper

Cancers

Volumn 3, Issue 2, 2011, Pages 2302-2315

  Grossmann, Irene ^a,b   Verberne, Charlotte ^b   de Bock, Geertruida ^b   Havenga, Klaas ^b   Kema, Ido ^b   Klaase, Joost ^c   Renehan, Andrew ^d   Wiggers, Theo ^b  

^a CATHARINA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Follow up; Metastases; Recurrent disease

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANALYTICAL PARAMETERS; ANTIGEN BLOOD LEVEL; ANTIGEN DETECTION; BLOOD LEVEL; CANCER STAGING; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FOLLOW UP; HIGH FREQUENCY DYNAMIC THRESHOLD; HUMAN; MEDICAL LITERATURE; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROGNOSIS; QUALITY OF LIFE; RECURRENCE RISK; RECURRENT CANCER; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SYSTEMATIC REVIEW;

EID: 79959742602     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3022302     Document Type: Review

References (51)

1. Bruinvels, D.J.; Stiggelbout, A.M.; Kievit, J.; van Houwelingen, H.C.; Habbema, D.F.; van de Velde, C.J.H. Follow-up of patients with colorectal cancer. A meta-analysis. Ann. Surg. 1994, 219, 174-182.
2. Tjandra, J.J.; Chan, M.K.Y. Follow-up after curative resection of colorectal cancer: A meta-analysis. Dis. Colon Rectum 2007, 50, 1783-1799.
3. Jeffery, G.M.; Hickey, B.E.; Hider, P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst. Rev. 2002, 1, CD002200.
4. Renehan, A.G.; Egger, M.; Saunders, M.P.; O'Dwyer, S.T. Impact on survival of intensive follow-up after curative resection of colorectal cancer: Systematic review and meta-analysis of randomized trials. BMJ 2002, 324, 1-8.
5. Kievit, J. Colorectal cancer follow-up: A reassessment of empirical evidence on effectiveness. Eur. J. Surg. Oncol. 2000, 26, 322-328.
6. Martin, E.W.; Cooperman, M.; Carey, L.C.; Minton, J.P. Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J. Surg. Res. 1980, 28, 389-394.
7. Minton, J.P.; hoehn, J.L.; Gerber, D.M.; Horsley, J.S.; Connoly, D.P.; salwan, F.; Fletcher, W.S.; Cruz, A.B.; Gatchell, F.G.; Oviedo, M.; et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985, 55, 1284-1290.
8. Ohlsson, B.; Breland, U.; Ekberg, H.; Graffner, H.; Tranberg, K.G. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis. Colon Rectum 1995, 38, 619-626.
9. Pietra, N.; Sarli, L.; Costi, R.; Ouchemi, C.; Grattarola, M.; Peracchia, A. Role of follow-up in management of local recurrence of colorectal cancer. A prospective randomized study. Dis. Colon Rectum 1998, 41, 1127-1133.
10. Secco, B.S.; Fardelli, R.; Gianquito, D.; Bonfante, P.; Baldi, E.; Ravera, G.; Derchi, L.; Ferraris, R. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: A prospective, randomized and controlled trial. Eur. J. Surg. Oncol. 2002, 28, 418-423.
11. Behbehani, A.I.; Al-Naqeeb, N.; Omar, Y.T.; El-Nas, S.A.; Al-Deen, A.S.; Awwad, A.; Al-Jazzaf, H.; Nasralla, M.Y.; Szymendera, J.J. Serial determinations of serum CEA in monitoring management of patients with colorectal carcinoma. Oncology 1990, 47, 303-307.
12. Lim, C.N.H.; McPherson, T.A.; McCelland, A.R.; McCoy, L.; Koch, M. Value of serial CEA determinations in a surgical adjuvant trial of colorectal and gastric carcinoma. J. Surg. Oncol. 1980, 14, 275-280.
13. Steele, G.; Ellenberg, S.; Ramming, K.; OConnell, M.; Moertel, C.; Lessner, H.; Bruckner, H.; Horton, J.; Schein, P.; Zamcheck, N.; et al. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann. Surg. 1982, 196, 162-169.
14. Hine, K.R.; Dykes, P.W. Serum CEA testing in the post-operative surveillance of colorectal carcinoma. Br. J. Cancer 1984, 49, 689-693.
15. Staab, H.J.; Anderer, F.A.; Stumpf, E.; Hornung, A.; Fischer, R.; Kieniger, G. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastro-intestinal cancer. Am. J. Surg. 1985, 149, 198-204.
16. Ovaska, J.T.; Järvinen, H.J.; Mecklin, J.P. The value of a follow-up programme after radical surgery for colorectal carcinoma. Scand. J. Gastroenterol. 1989, 24, 416-422.
17. Ovaska, J.T.; Järvinen, H.J.; Kujari, H.; Perttilä, I.; Mecklin, J.P. Follow-up of patients operated on for colorectal carcinoma. Am. J. Surg. 1990, 159, 593-596.
18. Makela, J.T.; Laitinen, S.O.; Kairaluoma, M.I. Five year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch. Surg. 1995, 130, 1062-1067.
19. McCall, J.L.; Black, R.B.; Rich, C.A.; Harvey, J.R.; Baker, R.A.; Watts, J.M.; Toouli, J. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis. Colon Rectum 1994, 37, 875-881.
20. Moertel, C.G.; Fleming, T.R.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A.; Tangen, C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993, 270, 943-947.
21. Schoemaker, D.; Black, R.; Giles, L.; Toouli, J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998, 114, 7-14.
22. Graham, R.A.; Wang, S.; Catalano, P.J.; Haller, D.G. Postsurgical surveillance of colon cancer: Preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray and colonoscopy. Ann. Surg. 1998, 228, 59-63.
23. Wichmann, M.W.; Lau-Werner, U.; Müller, C.; Hornung, H.M.; Stieber, P.; Schildberg, F.W. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res. 2000, 20, 4953-4956.
24. Komborozos, V.A.; Skrekas, G.J.; Pissiotis, C.A. The contribution of follow-up programs in the reduction of mortality of rectal cancer recurrence. Dig. Surg. 2001, 18, 403-408
25. Bleeker, W.A.; Mulder, N.H.; Hermans, J.; Otter, R.; Plukker, J.T.M. Value and cost of follow-up after adjuvant treatment of patients with Dukes C colonic cancer. Br. J. Surg. 2001, 88, 101-106.
26. Glover, C.; Douse, P.; Kane, P.; Karani, J.; Meire, H.; Mohammadtagi, S.; Allen-Mersh, T.G. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis. Colon Rectum 2002, 45, 476-484.
27. Chau, I.; Allen, M.J.; Cunningham, D.; Norman, A.R.; Brown, G.; Ford, H.E.R.; Tebbutt, N.; Tait, D.; Hill, M.; Ross, P.J.; Oates, J. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J. Clin. Oncol. 2004, 22, 1420-1429.
28. Bonthuis, D.C.; Landheer, M.L.E.A.; Spillenaar Bilgen, E.J.; Slootmans, F.C.W.; van Lier, H.; Klinkenbijl, J.H.G.; Wobbes, Th. Small but significant survival benefit in patients who undergo routine follow-up after colorectal cancer surgery. Eur. J. Surg. Oncol. 2004, 30, 1093-1097.
29. Grossmann, E.M.; Johnson, F.E.; Virgo, K.S.; Longo, W.E.; Fossati, R. Follow-up of colorectal cancer patients after resection with curative intent-The GILDA trial. Surg. Oncol. 2004, 13, 119-124.
30. Rodriguez-Moranta, F.; Salo, J.; Arcusa, A.; Boadas, J.; Pinol, V.; Bessa, X.; Batista-Alentorn, E.; Lacy, A.M.; Delgado, S.; Maurel, J.; et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: A prospective multicenter randomized controlled trial. J. Clin. Oncol. 2006, 24, 386-393.
31. Fernandes, S.C.; Kim, S.B.; Saad, S.S.; Matos, D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J. Gastroenterol. 2006, 12, 3891-3894.
32. Cooper, G.S.; Kou, T.D.; Reynolds, H.L. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: A population-based study. Cancer 2008, 113, 2029-2037.
33. Spratlin, J.L.; Hui, D.; Hanson, J.; Butts, C.; Au, H.J. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer. Clin. Colorectal Cancer 2008, 7, 118-125,
34. Grossmann, I.; de Bock, G.H.; van de Velde, C.J.H.; Kievit, J.; Wiggers, T. Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up. Colorectal Dis. 2007, 9, 787-792.
35. Yamamoto, M.; Maehara, Y.; sakaguchi, Y.; Mine, H.; Yamanaka, T.; Korenaga, D.; Okamura, T. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas. Hepatogastroenterology 2004, 51, 147-151.
36. Grossmann, I.; de Bock, G.H.; Meershoek-Klein Kranenbarg, W.M.; van de Velde, C.J.H.; Wiggers, T. CEA measurement during follow-up for colorectal carcinoma is useful even if normal levels exist before curative surgery. Eur. J. Surg. Oncol. 2007, 33, 183-187.
37. Gastro-enterology colon,Cancer. http://www.oncoline.nl/ (accessed 10 April 2011).
38. Staab, H.J.; Anderer, F.A.; Stumpf, E.; Fischer, R. Slope analysis of the post-operative CEA time course and it's possible application as an aid in diagnosis of disease progression in gastro-intestinal cancer. Am. J. Surg. 1978, 136, 322-327.
39. Staab, H.J.; Anderer, F.A.; Hornung, A.; Stumpf, E.; Fischer, R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br. J. Cancer 1982, 46, 773-781.
40. Reinauer, H.; Wood, W.G. External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity. Ger. Med. Sci. 2005, 3, doc02.
41. Biological variation database. http://www.westgard.com/biodatabase1.htm/ (accessed 10 May 2011).
42. Carriquiry, L.; Pineyro, A. Should CEA be used in the management of patients with colorectal cancer? Dis. Colon Rectum 1999, 42, 921-929.
43. Carl, J.; Bentzen, S.M.; Nørgaard-Pedersen, B.; Kronborg, O. Modelling of serial carcinoembryonic antigen changes in colorectal cancer. Scand. J. Clin. Lab. Invest. 1993, 53, 751-755.
44. Boey, J.; Cheung, H.C.; Lai, C.K.; Wong, J. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. World J. Surg. 1984, 8, 279-286.
45. Staab, H.J.; Anderer, F.A. Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease. Canc. Detect. Prev. 1983, 6, 33-39.
46. Umehara, Y.; Kimura, T.; Yoshida, M.; Oba, N.; Harada, Y. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Cancer 1993, 71, 4055-4059.
47. Korenaga, D.; Saeki, H.; Mawatari, K.; Orita, H.; Maekawa, S.; Ikeda, T.; Sugimachi, K. Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma. Arch. Surg. 1997, 132, 188-194.
48. Irvine, T.; Scott, M.; Clark, C.I. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer. Colorectal Dis. 2007, 9, 527-531
49. Tanaka, K.; Noura, S.; Ohue, M.; Seki, Y.; Yamada, T; Miyashiro, I; Ohigashi, O; Murata, K; Kameyama, M; Imaoka, S. Doubling time of carcinoem bryonic antigen is a significant prognostic factor after surgical resection of locally recurrent rectal cancer. Dig. Surg. 2008, 25, 319-324.
50. Verberne, C.J.; Nijboer, C.H.; de Bock, G.H.; Grossmann, I; Wiggers, T; Havenga, K. Evaluation of decision-support software in Carcino-Embryonic Antigen (CEA)-based follow-up of colorectal cancer patients. BMC Med. Inform. Decis. 2011, submitted.
51. Reijnen, I; Grossmann, I; Kommers, P.A.M.; Drossaert, C.H.C.; Klaase, J.M.; Wiggers, T; de Bock, G.H. Intensive oncological follow-up pursued with less outpatient clinic visits: A preferred strategy according to colorectal cancer patients. Br. J. Caner 2011, submitted.